Solventum Co. (NYSE:SOLV) Shares Sold by TrinityPoint Wealth LLC

TrinityPoint Wealth LLC reduced its position in Solventum Co. (NYSE:SOLV - Free Report) by 38.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,497 shares of the company's stock after selling 13,148 shares during the quarter. TrinityPoint Wealth LLC's holdings in Solventum were worth $1,499,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Deseret Mutual Benefit Administrators acquired a new position in shares of Solventum in the second quarter worth about $25,000. Hollencrest Capital Management purchased a new stake in shares of Solventum during the second quarter worth about $25,000. Partnership Wealth Management LLC purchased a new stake in Solventum during the 2nd quarter valued at about $26,000. Richard W. Paul & Associates LLC purchased a new stake in Solventum during the 2nd quarter valued at about $26,000. Finally, Family Firm Inc. purchased a new stake in Solventum during the 2nd quarter valued at about $26,000.

Analysts Set New Price Targets

Several equities analysts have weighed in on SOLV shares. Piper Sandler boosted their target price on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Wells Fargo & Company reduced their target price on shares of Solventum from $69.00 to $64.00 and set an "equal weight" rating on the stock in a report on Friday, August 9th. BTIG Research began coverage on shares of Solventum in a research report on Thursday, September 5th. They issued a "neutral" rating on the stock. Wolfe Research began coverage on shares of Solventum in a research report on Thursday, September 26th. They issued a "peer perform" rating on the stock. Finally, The Goldman Sachs Group increased their price objective on shares of Solventum from $48.00 to $54.00 and gave the company a "sell" rating in a research report on Monday, August 12th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Solventum presently has an average rating of "Hold" and an average price target of $68.00.

Solventum Trading Down 0.5 %

Shares of NYSE SOLV traded down $0.36 during midday trading on Monday, reaching $67.12. 939,073 shares of the stock were exchanged, compared to its average volume of 1,730,362. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The stock has a 50 day moving average price of $70.54 and a 200-day moving average price of $62.18. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.